(Q46389817)

English

Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary angiography

1 reference

based on heuristic

inferred from title

Dominic Y. Leung

9

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

author name string

C P Juergens

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

J P Winter

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

P Nguyen-Do

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

S Lo

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

J K French

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

H Hallani

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

C Fernandes

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

N Jepson

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

publication date

2 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

Internal Medicine Journal

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

39

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

25-31

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Nephrotoxic effects in high-risk patients undergoing angiography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Epidemiology and prognostic implications of contrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Contrast nephropathy: review focusing on prevention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Acute renal failure requiring dialysis after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Clinical practice. Preventing nephropathy induced by contrast medium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01675.X

21 January 2018

Identifiers

10.1111/J.1445-5994.2008.01675.X

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18771430

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46389817&oldid=2109185980"